All Stories

  1. Correction of Androgen Deficiency in Men with Type 2 Diabetes
  2. Metabolic Benefits of Probiotic Combination with Absorbent Smectite in type 2 Diabetes Patients a Randomised Controlled Trial
  3. Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A randomised controlled trial
  4. Probiotics function and modulation of the immune system in allergic diseases
  5. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment
  6. Combined effects of probiotic and chondroprotector during osteoarthritis in rats
  7. Crosstalk between gut microbiota and osteoarthritis: A critical view
  8. New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study
  9. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells
  10. Probiotics and smectite absorbent gel formulation reduce liver stiffness, transaminase and cytokine levels in NAFLD associated with type 2 diabetes: a randomized clinical study
  11. Effect of probiotic on serum cytokines and matrix metalloproteinases profiles during monoiodoacetate-induced osteoarthritis in rats
  12. Neuropathic diabetic foot ulcers treated with cerium dioxide nanoparticles: A case report
  13. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
  14. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
  15. Wpływ Z56822977 na biosyntezę serotoniny w mózgu szczurów z otyłością wywołaną przez podawanie glutaminianu sodu
  16. The correction of the metabolic parameters of msg-induced obesity in rats by 2-[4-(benzyloxy) phenoxy] acetic acid
  17. Probiotics and nutraceuticals as a new frontier in obesity prevention and management
  18. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial
  19. A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
  20. Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease
  21. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders
  22. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
  23. H 2 S causes contraction and relaxation of major arteries of the rabbit
  24. Effects of polyphenol compounds melanin on NAFLD/NASH prevention
  25. The Impact of Hyperglycemia on VEGF Secretion in Retinal Endothelial Cells
  26. Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress
  27. Perspectives and challenges of antioxidant therapy for atrial fibrillation
  28. Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
  29. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity
  30. The Role of Liver Biopsy to Assess Alcoholic Liver Disease
  31. Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles
  32. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention
  33. Caffeine and cardiovascular diseases: critical review of current research
  34. Probiotics in prevention and treatment of obesity: a critical view
  35. Pathophysiological role of host microbiota in the development of obesity
  36. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition
  37. Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility
  38. Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients
  39. P0968 : Are the type of probiotic strains and their amount equally effective for NAFLD prevention? Experimental comparative study
  40. The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease
  41. Multiprobiotic therapy from childhood prevents the development of nonalcoholic fatty liver disease in adult monosodium glutamate-induced obese rats
  42. P269 SHORT-TERM PERIODIC ADMINISTRATION OF MULTIPROBIOTIC FROM CHILDHOOD PREVENTS DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN ADULT MONOSODIUM GLUTAMATE-INDUCED OBESE RATS
  43. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
  44. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
  45. Metabolic profile and morpho-functional state of the liver in rats with glutamate-induced obesity
  46. 1329 DIAGNOSTIC ACCURACY OF A NEW ELASTOGRAPHIC METHOD (SHEAR WAVE™ ELASTOGRAPHY IMAGING) IN THE NONINVASIVE ASSESSMENT OF NON-ALCOHOLIC STEATOSIS IN PATIENTS WITH TYPE 2 DIABETES
  47. 1267 PERFORMANCE OF NEW ULTRASOUND METHOD FOR ASSESSING LIVER STIFFNESS – SHEAR WAVE™ ELASTOGRAPHY IMAGING IN RATS WITH EXPERIMENTAL OBESITY